Fleury (BSP:FLRY3) FFO


BSP:FLRY3 Fleury SA BSP:FLRY3
91 GF Score
Price R$15.61
GF Value R$17.41
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Fleury FFO?

FFO (Funds from operations) only applies to REITs.

BSP:FLRY3
91GF Score
Fleury SA BSP:FLRY3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fleury (BSP:FLRY3) Overvalued in 2026?

Based on GuruFocus' analysis, Fleury stock appears to be undervalued. The current stock price of R$15.61 is trading 10.3% below its estimated GF Value™ of R$17.41. GuruFocus considers Fleury to be Modestly Undervalued.

Key valuation signals for BSP:FLRY3:

  • FFO:
  • GF Value™: R$17.41 vs. price of R$15.61 (10.3% below fair value)
  • GF Score™: 91/100 with 4 warning signs

No single metric tells the full story. See the BSP:FLRY3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Fleury Business Description

Address Avenida Morumbi 8.860, 8th floor, Brooklin, Sao Paulo, SP, BRA, 04703-002
Fleury SA is engaged in the provision of medical services in the diagnostic, laboratory support (Lab-to-Lab), infusions, clinical analysis, health management, medical care, orthopedics and ophthalmology, fertility, infusion areas and toxicological exams, among others. The company offers diagnostic medicine through physical service units and mobile diagnostic services for consumers. It also provides diagnostic support services to laboratories and hospitals. In addition, the company operates clinics and services in areas such as infusion therapy, orthopedics, ophthalmology, reproductive medicine, and oncology. It has two reportable business segments: Diagnostic Medicine and Integrated Medicine. The maximum revenue is generated from the Diagnostic Medicine Segment.
91GF Score

Get the complete analysis for BSP:FLRY3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$15.61
Price
R$17.41
GF Value